Evidence map›Paper›PMID 28324410›Full record

Article3 Biotech2015

Synthesis, characterization and antimicrobial properties of green-synthesised silver nanoparticles from stem bark extract of Syzygium alternifolium (Wt.) Walp.

Pulicherla Yugandhar, Reddla Haribabu, Nataru Savithramma

Open access · hybridAbstract read
In one paragraph

Article in 3 Biotech, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Are Biogenic and Pyrogenic Mesoporous SiOMolecules (Basel, Switzerland) · 2021
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Pulicherla YugandharDepartment of Botany, Sri Venkateswara University, Tirupati, 517502, A.P, India. yugandharbotany@gmail.com.
Reddla HaribabuDepartment of Botany, Sri Venkateswara University, Tirupati, 517502, A.P, India.
Nataru SavithrammaDepartment of Botany, Sri Venkateswara University, Tirupati, 517502, A.P, India.
Sri Venkateswara University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today green synthesis of silver nanoparticles (SNPs) from plants is an utmost emerging filed in nanotechnology. In the present study, we have reported a green method for synthesis of SNPs from aqueous stem bark extract of Syzygium alternifolium, an endemic medicinal plant of South Eastern Ghats. These green-synthesised nanoparticles are characterised by colour change pattern, and the broad peak obtained at 448 nm with UV-Vis surface plasmon resonance studies confirm that the synthesised nanoparticles are SNPs. FT-IR spectroscopic studies confirm that phenols and proteins of stem bark extract is mainly responsible for capping and stabilisation of synthesised SNPs. Crystallographic studies from XRD indicates, the SNPs are crystalline in nature owing to 44 nm size. EDAX analysis shows 19.28 weight percentage of Ag metal in the sample indicates the purity of sample. AFM, SEM and TEM microscopic studies reveal that the nanoparticles are spherical in shape with sizes ranging from 4 to 48 nm. Antimicrobial studies of the synthesised SNPs on clinically isolated microbes showed very toxic effects. It indicates that stem bark extract of S. alternifolium is suitable for synthesising stable silver nanoparticles which act as excellent antimicrobial agents.

Indexed as

AFMAntimicrobial activityFT-IRGreen synthesisSEM with EDAXSilver nanoparticlesSyzygium alternifoliumTEMUV–VisXRD

Identifiers

PMID28324410
PMCPMC4624132
OpenAlexW2124773454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.